Tregs are critical for control of self-reactive T cells that escape thymic selection and end up in the periphery. Treg subsets suppress effector T cell populations through the secretion of immunosuppressive molecules and inhibitory cytokines as well as cell contact-dependent mechanisms. In this issue of the JCI, Wen and colleagues describe another mechanism by which Tregs suppress effector T cell populations. Specifically, the authors reveal that CD8 + T cells in close contact with target T cells release NADPH oxidase 2-containing microvesicles that inhibit TCR activation by elevating ROS and thereby reducing phosphorylation of the TCR-associated kinase ZAP70. Together, the results of this study provide important insight into CD8 + Treg function and into the development of autoimmunity in older individuals.
Tregs: mediators of peripheral tolerance
During development, deletion of selfreactive T cells in the thymus is incomplete, and escape of these potentially autoaggressive T cells into the periphery is not the exception, but the rule. Control of these T cells in peripheral tissues (peripheral tolerance) is key to prevent autoimmunity -a task that is fulfilled by so-called Tregs. Individuals with dysfunction of the transcriptional regulator FOXP3 lack Tregs and develop severe autoimmune disease, a testament to the importance of this population in maintaining peripheral tolerance (1). Regulation of peripheral tolerance has been extensively studied in CD4 + T cells; however, suppressive capacity is not strictly confined to the CD4 + T cell compartment. CD8 + Tregs, which have been characterized by various investigators via a range of cell surface phenotypes, have been described in both humans and mice (2) . The capacity to suppress T cell proliferation and/or function is common to all Treg subsets. Similar to their CD4 + counterparts, CD8 + Tregs have been reported to exert inhibition through cell-cell contact or via secretion of immunosuppressive molecules and inhibitory cytokines, such as IL-10. Alterations in the CD8 + Treg compartment have been described in human autoimmune diseases, including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematodes (2) . As systemic inflammation affects many of the phenotypic markers used to track Tregs and as there is an absence of a genetically defined disease associated with a selective lack of CD8 + Tregs, the in vivo relevance of this regulatory subset has been discussed with some skepticism.
In Figure 1A ). The authors demonstrated that CD8 + Tregs form a synapse, with clustering of NOX2 in the contact area (3). These NOX2-enriched areas of the membrane are released as extracellular vesicles and fuse with the neighboring CD4 + T cells, thus delivering NOX2 and hence ROS to reduce ZAP70 phosphorylation. NOX2/ ROS-mediated cell suppression occurred very rapidly (within minutes after NOX2 microvesicle transfer) yet left targeted CD4 + T cells stunned for several days. These observations add another facet to our understanding of the various functions of ROS. Given the broad spectrum of potential ROS targets (4), it is likely that NOX2 microvesicles have additional effects beyond ZAP70 phosphorylation. Furthermore, in addition to the delivery of NOX2 and ROS, microvesicles have been speculated to harbor many more biologically important molecules, such as specific RNAs or signaling molecules (5, 6) . The study by Wen et al. thus extends the list of candidate microvesicles that might become interesting therapeutic targets, with the aim of modulating the immune system (7). Tregs are critical for control of self-reactive T cells that escape thymic selection and end up in the periphery. Treg subsets suppress effector T cell populations through the secretion of immunosuppressive molecules and inhibitory cytokines as well as cell contact-dependent mechanisms. In this issue of the JCI, Wen and colleagues describe another mechanism by which Tregs suppress effector T cell populations. Specifically, the authors reveal that CD8 + T cells in close contact with target T cells release NADPH oxidase 2-containing microvesicles that inhibit TCR activation by elevating ROS and thereby reducing phosphorylation of the TCRassociated kinase ZAP70. Together, the results of this study provide important insight into CD8 + Treg function and into the development of autoimmunity in older individuals. + Treg function due to absence of NOX2. Large-vessel vasculitis, such as Takayasu's arteritis or GCA, however, has not been described in patients with CGD to date. It will be important to define the role of CD8 + Tregs in additional agerelated inflammatory conditions, such as late-onset rheumatoid arthritis or atherosclerosis. In particular, late-onset rheumatoid arthritis might be a good starting point, as NOX-deficient mice develop spontaneous, age-related arthritis that involves CD4 + T cell expansion (18) . In addition to these inflammatory conditions, many more interesting and clinically important questions need to be revisited in light of this report ( Figure  1B ). For example, do viruses that establish chronic persistence -such as HIV cell-mediated damage of the vessel wall (9) . A model in which age-related loss of peripheral tolerance due to a decline of CD8 + Treg function that allows expansion of autoreactive T cells is therefore an intriguing possibility. Additionally, recent translational studies found normal or only slightly reduced CD4 + Treg numbers (10-12) but normal CD4 + Treg function (11) in patients with GCA.
Clinical implications and future directions
With the spotlight on NOX2, studying CD8 + Tregs in the pathology of chronic granulomatous disease (CGD) may be highly informative. Patients with CGD harbor mutations in genes encoding for NOX (most commonly gp91-PHOX on the X chromosome) (13) and suffer from recurrent infections and bowel inflammation reminiscent of Crohn's disease. Other autoimmune manifestations -typically lupus-like autoinflammatory syndromes -occur in roughly 1 of 10 patients with CGD (14) . Further, case reports of children with CGD have described the Having unraveled the cellular mechanisms, Wen and colleagues went on to demonstrate that the function of CD8 + Tregs inversely correlates with age (3). In aged, healthy individuals, T cells have an augmented activation threshold (8); therefore, the reduction of CD8 + Treg function may reflect a physiologic balancing response to maintain protective immunity. However, if this balancing act fails, dysfunctional CD8 + Tregs may allow self-reactive T cell clones to expand. Wen et al. explored this possibility in a clinical context by studying giant cell arteritis (GCA). GCA is a paradigm of autoimmune disease in the elderly that is characterized by inflammation of large arteries. In support of the notion that loss of CD8 + Treg function may be linked to development of autoimmune disease, NOX2 coexpressing CD8 + Tregs were almost completely lacking in patients with GCA. T cells are thought to be important for establishing and/or maintaining vascular inflammation in GCA, and immunophenotypic, histopathologic, and genetic studies all point to Th1 and Th17 CD4 + T (19) . Eventually, sophisticated comprehensive network analyses that incorporate dynamic changes of cellular functions over time may be required to firmly dissect the appropriate targets, possibly including CD8 + Tregs, for high-precision immunoregulatory therapies.
Irrespective of how these intriguing issues are approached, it should be remembered that is has taken three decades to appreciate the importance of CD4 + Tregs -we should be more open-minded this time around.
